<DOC>
	<DOC>NCT00915356</DOC>
	<brief_summary>This study is being carried out to see which dose of AZD1305 is safe and effective in cardioverting atrial fibrillation into normal heart rhythm.</brief_summary>
	<brief_title>Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Clinical indication for cardioversion of Atrial Fibrillation, ie a correction of irregular heart rhythm to normal heart rhythm Current episode of Atrial Fibrillation (ie irregular heart rhythm) lasting up to 3 months at randomisation Adequate anticoagulation according to international guidelines (ACC/AHA/ESC, 2006) or national guidelines Potassium level below 3.8 mmol/L measured in serum or plasma QTcF interval &gt;440 ms</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>AZD1305</keyword>
	<keyword>intravenous cardioversion of Atrial Fibrillation</keyword>
</DOC>